Invest now

Laurus Labs Profit & Loss Annual

BSE: 540222 | NSE: LAURUSLABS | ISIN: INE947Q01028 | Sector: Biotechnology & Drugs
2,052.00 -2.00 (-0.10%)Updated : 07 Oct 2026
Research on
Fiscal Period2026202520242023
Period End DateMar 26Mar 25Mar 24Mar 23
Total Operating Expense 5,507.284,928.774,645.984,746.91
Other Net 11.30-6.029.17-18.66
Diluted Weighted Average Shares 54.0553.9653.9753.96
Gain( Loss)on Saleof Assets -7.4857.05-1.93-0.21
Depreciation/ Amortization 480.05430.09384.58324.08
Operating Income 1,305.62625.19394.851,293.64
Net Income 888.79358.32160.55790.11
Income Availableto Com Excl Extra Ord 888.79358.32160.55790.11
Other Operating Expenses Total 1.790.240.130.73
Net Income Before Taxes 1,181.88484.29236.361,108.94
Minority Interest -1.35-0.02-1.72-3.32
Net Income After Taxes 889.85354.41168.21796.64
Income Availableto Com Incl Extra Ord 888.79358.32160.55790.11
Costof Revenue Total 3,134.782,862.812,837.243,164.81
Gross Profit 3,678.122,691.152,203.592,875.74
Interest Inc( Exp) Net- Non- Op Total -127.56-191.93-165.73-165.83
Unusual Expense( Income) -0.48---
Diluted Net Income 888.79358.32160.55790.11
DPS- Common Stock Primary Issue 2.001.200.801.20
Provisionfor Income Taxes 292.03129.8868.15312.30
Equity In Affiliates 0.293.93-5.94-3.21
period Type ----
Net Income Before Extra Items 888.79358.32160.55790.11
Total Revenue 6,812.905,553.965,040.836,040.55
period Length 12.0012.0012.0012.00
Revenue 6,812.905,553.965,040.836,040.55
Selling/ General/ Admin Expenses Total 1,891.141,635.631,424.031,257.29
Diluted Normalized EPS 16.545.873.0014.65
Diluted EPS Excluding Extra Ord Items 16.456.642.9714.64
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,035.00+40.00(4.02%)
1,246.00+17.00(1.38%)
11,400.00-549.00 (-4.59%)